Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-23

Clinical Trial Update: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating autologous adipose-derived stromal vascular fraction for knee osteoarthritis is currently active but not recruiting. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous adipose-derived stromal vascular fraction

Snippet

Sponsor: GID BIO, Inc. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: ACTIVE_NOT_RECRUITING